Ischemic Stroke Caused by Left Ventricular Cardiac Myxoma: Case Report

Main Article Content

Ruiz Gómez Maria Fernanda
Valeria Guadalupe Caldera Gonzalez
Selene Mercado Silvia
Gilberto Flores Hernandez
Sandoval Correa Santiago
Roberto de Jesus Martinez Camacho
Ivonne Alejandra Perales Soto
Erick Fernando Murillo Duarte
Valdes Acis Jimena
Luis Carlos Caporal Trejo
Rafael Cabrales García
Eduardo Nieves Paredes
Norma Lizeth Lira Zatarain

Abstract

Primary heart tumors are a rare entity among neoplasms, among them myxoma is the main lesion reported in more than 50% of cases. Myxomas are generally located in the left atrium, however they can be located in any cardiac chamber. Its diagnosis is usually incidental, after some complication, mainly thromboembolic. Transthoracic echocardiography is the first diagnostic method used, however, biopsy with immunohistochemistry is the gold standard.

Article Details

How to Cite
Ruiz Gómez Maria Fernanda, Valeria Guadalupe Caldera Gonzalez, Selene Mercado Silvia, Gilberto Flores Hernandez, Sandoval Correa Santiago, Roberto de Jesus Martinez Camacho, Ivonne Alejandra Perales Soto, Erick Fernando Murillo Duarte, Valdes Acis Jimena, Luis Carlos Caporal Trejo, Rafael Cabrales García, Eduardo Nieves Paredes, & Norma Lizeth Lira Zatarain. (2023). Ischemic Stroke Caused by Left Ventricular Cardiac Myxoma: Case Report. International Journal of Medical Science and Clinical Research Studies, 3(11), 2623–2626. https://doi.org/10.47191/ijmscrs/v3-i11-15
Section
Articles

References

I. Latifi AN, Uzochukwy I, Gnanaraj J. A case report of atrial myxoma presenting with systemic embolization and myocardial infarction. Euro Heart J 2019; 3: 1-5.

II. Presta I, Donato A, Chirchiglia D, Malara N, Guiseppe D. Cardiac Myxoma and Neural Crests: a tense relationship. , Cardiov Path, 2019;https://doi.org/10.1016/j.carpath.2019.107163.

III. Islam AKMM. Cardiac myxomas: A narrative review. World J Cardiol 2022; 14(4): 206-219. DOI: 10.4330/wjc.v14.i4.206.

IV. McAllister, BJ. Multi Modality Imaging Features of Cardiac Myxoma. J Cardiovasc Imaging 2020; 28(4):235-243. https://doi.org/10.4250/jcvi.2020.0027

V. Velez TJM, Martinez DE, Diaz PJA, Rosernberg AE. Cardiac Myxoma: Review and update of contemporary immmunohistochemical markers and molecular ahotology. Adv Anat Pathol 27(6): 380-384.

VI. Wen X-Y, Chen Y-M, Yu L-L, Wang S-R, Zheng H-B, Chen Z-B, et al. Neurological manifestations of atrial myxoma: A retrospective analysis. Oncol Lett 2018;16(4):4635-4639. http://dx.doi.org/10.3892/ol.2018.9218.

VII. Li Y, Yang W, Liao S, Zuo H, Liu M. Cardiac myxomas as great imitators: A rare case series and review of the literature. Heart Lung. 2022;52:182-189. http://dx.doi.org/10.1016/j.hrtlng.2022.01.010.

VIII. Fabijanić D, Carević V, Bečić T, Pešutić-Pisac V. Cardiac myxoma: benign, but deadly disease. Med Ultrason 2022, 24(2): 248-260. DOI: 10.11152/mu-3612.

IX. Javaid A, Khandait H, Ong CK. Left atrial myxoma with coronary artery disease. BMJ Case Rep. 2022;15(10). http://dx.doi.org/10.1136/bcr-2022-252905

X. Kacar P, Pavsic N, Bervar M, Strazar Z, Zadnik V, Jelenc M, Prokselj K. Cardiac myxoma: single tertiary center experience. Radiol Oncol, 2022; 56(4): 535-540.

XI. Aggeli C, Dimitroglou Y, Raftopoulos L, Sarri G, Mavrogeni S, Wong J, et al. Cardiac masses: The role of cardiovascular imaging in the differential diagnosis. Diagnostics (Basel). 2020;10(12):1088. http://dx.doi.org/10.3390/diagnostics10121088

Most read articles by the same author(s)